Taconic Biosciences offers a number of Live and Cryopreserved models for Parkinson's Disease (PD) research. Click each card to learn more about the model.
Learn more about Taconic Biosciences' partnership with The Michael J. Fox Foundation
"The Michael J. Fox Foundation (MJFF) is dedicated to finding a cure for Parkinson's disease (PD) through an aggressively funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's today. The MJFF Research Tools Program supports this mission through the development, characterization, and distribution of high-quality reagents and models for PD research. Taconic Biosciences has partnered with MJFF in this program since 2010, generating and sharing critical rodent models for PD research. These models and other reagents generated by the MJFF Research Tools Program can be found at michaeljfox.org/research-tools."
- Nicole Polinski, Director of Research Resources
The Michael J. Fox Foundation for Parkinson’s Research
Taconic Biosciences offers a number of Live and Cryopreserved models for Parkinson's Disease (PD) research. Click each card to learn more about the model.
22966 | April 2025
22966 | April 2025
22640 | June 2025
22574 | June 2025
22952 | July 2025
December 2025
23196 | Spring 2026
Mouse models play a crucial role in Parkinson's disease (PD) research by replicating human disease mechanisms, enabling the study of genetic contributions, testing new treatments, and advancing personalized medicine. These models, including genetically modified mice, mimic the degeneration of dopamine-producing neurons, allowing researchers to explore the progression of PD and identify potential intervention points. They are invaluable in testing new therapies, screening drugs, and investigating disease pathways, such as the accumulation of alpha-synuclein and Lewy body formation. Additionally, mouse models help researchers better understand genetic factors by creating transgenic mice that carry specific PD-related mutations, and they are essential in developing more tailored treatment approaches. Ultimately, these models are key to discovering effective treatments and working toward a cure for Parkinson’s disease.
The Michael J. Fox Foundation (MJFF) exists for one reason: to accelerate the next generation of Parkinson’s disease (PD) treatments. In practice, that means identifying and funding projects most vital to patients; spearheading solutions around seemingly intractable field-wide challenges; coordinating and streamlining the efforts of multiple, often disparate, teams; and doing whatever it takes to drive faster knowledge turns for the benefit of every life touched by PD.